A detailed history of Eagle Claw Capital Managment, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 27,644 shares of PFE stock, worth $728,695. This represents 0.14% of its overall portfolio holdings.

Number of Shares
27,644
Previous 28,394 2.64%
Holding current value
$728,695
Previous $794,000 0.76%
% of portfolio
0.14%
Previous 0.15%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$27.7 - $31.39 $20,775 - $23,542
-750 Reduced 2.64%
27,644 $800,000
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $25,890 - $29,730
1,000 Added 3.65%
28,394 $787,000
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $72,781 - $84,206
-2,015 Reduced 6.85%
27,394 $1 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $44,923 - $58,642
1,076 Added 3.8%
29,409 $1.51 Million
Q4 2022

Feb 06, 2023

SELL
$41.75 - $54.5 $44,923 - $58,642
-1,076 Reduced 3.66%
28,333 $1.45 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $61,307 - $74,841
1,401 Added 5.0%
29,409 $1.29 Million
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $80,310 - $95,223
-1,726 Reduced 5.8%
28,008 $1.47 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $37,743 - $46,769
-825 Reduced 2.7%
29,734 $1.54 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $24,792 - $36,750
600 Added 2.0%
30,559 $1.81 Million
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $24,531 - $31,512
625 Added 2.13%
29,959 $1.29 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $31,815 - $35,881
950 Added 3.35%
29,334 $1.06 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $174,044 - $221,312
-5,200 Reduced 15.48%
28,384 $1.05 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $203,676 - $238,958
6,415 Added 23.61%
33,584 $1.23 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $476,016 - $577,478
-15,804 Reduced 36.78%
27,169 $888,000
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $24,327 - $34,758
900 Added 2.14%
42,973 $1.4 Million
Q4 2019

Jan 27, 2020

BUY
$32.92 - $37.36 $460,649 - $522,778
13,993 Added 49.83%
42,073 $1.65 Million
Q3 2019

Oct 22, 2019

BUY
$32.49 - $42.13 $418,341 - $542,465
12,876 Added 84.69%
28,080 $1.01 Million
Q2 2019

Jul 18, 2019

SELL
$36.98 - $41.52 $5,066 - $5,688
-137 Reduced 0.89%
15,204 $657,000
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $11,541 - $13,158
300 Added 1.99%
15,341 $670,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $254,181 - $308,306
7,374 Added 96.18%
15,041 $662,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $4,122 - $4,395
125 Added 1.66%
7,667 $278,000
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $250,846 - $266,157
7,542
7,542 $273,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Eagle Claw Capital Managment, LLC Portfolio

Follow Eagle Claw Capital Managment, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.